P-Nitrosophosphates, such as 9, react as N-O heterodienophiles with 1,3-dienes to form highly functionalized cycloadducts that can be directly transformed into allylic phosphoramidates. The in situ periodate oxidation of the unstable N-hydroxyphosphoramidate precursors provides an efficient preparation of these new reactive intermediates. P-Nitrosophosphate (9) regioselectively reacts with 1-methoxy-1,3-butadiene to provide cycloadduct 16. P-Nitrosophosphate (9) also reacts with 9,10-dimethylanthracene to give cycloadduct 17, which undergoes retro Diels-Alder dissociation to re-form 9. In the absence of a 1,3-diene, the decomposition of 17 produces nitrous oxide, evidence for nitroxyl, the one-electron-reduced form of nitric oxide. An asymmetric P-nitrosophosphate reacted with 1,3-cyclohexadiene to form a mixture of diastereomeric cycloadducts (19 and 20) in a 1.6:1 ratio. These results identify P-nitrosophosphates as new species that react similarly to acyl nitroso compounds, making them useful synthetic intermediates and potential nitroxyl delivery agents.
No takes yet. Share an insight, caveat, or question.
Ware et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: